Welcome to ACC's Cardio-Oncology Member Section!
Diego B. Sadler, MD, FACC
Chair
Novel and established cancer therapeutics have led to a substantial increase in cancer survivors. New therapeutics for cancer continue to grow exponentially, and a number of these therapies are associated with short and/or long-term adverse cardiovascular effects, some of which are unknown at this time. In addition to the risk of recurrent cancer, one of the greatest risks for cancer survivors is morbidity and mortality related to early and late cardiovascular toxicities.
The Cardio-Oncology clinicians strive to provide comprehensive cardiac care to patients who have co-existing heart disease and cancer, and to prevent and treat the cardiovascular complications of cancer therapeutics in patients undergoing cancer therapy and in cancer survivors. They aim to limit interruptions or delays in cancer therapy due to cardiovascular reasons.
The ACC Cardio-Oncology section strives to be the home for the ACC Cardio-Oncology clinicians, educators, researchers, and trainees across the stages of their careers. The section aims to support interest, education, and collaboration amongst the members in order to generate interest in this field, to advocate for and provide better care for their patients, to understand mechanisms of cardiovascular toxicity, and to grow the number of clinicians and programs with expertise in the cardiovascular care of patients with cancer and of cancer survivors.
We welcome your active participation!
Join the Cardio-Oncology Member Section — Today!
The Cardio-Oncology Member Section is only able to accomplish its mission through support from members. Members can join online by clicking here or by contacting ACC Member Care at (800) 253-4636, ext. 5603; or direct dial (202) 375-6000.
Already a member of the Cardio-Oncology Member Section? Click here to unlock the member exclusive section experience.
As our membership grows, so does the Cardio-Oncology Member Section's opportunities to impact College policies and provide additional member benefits.
Questions? Contact ACC Member Care.
Section Announcements
September 9, 2026
Do you know someone making meaningful contributions to the cardiovascular profession? ACC's 2027 Distinguished Awards recognize outstanding individuals through one of the 15 awards spanning leadership and excellence in education, service, mentorship, research and more. Nominations are due by Thursday, Sept. 17 at 1 p.m. ET. Learn more and nominate a colleague today!
September 9, 2026
Transform the future of cardiovascular medicine by sharing your research with the global cardiovascular community at ACC.27 Together With WCC (ACC.27-WCC), taking place April 10-12, 2027, in Houston, TX. The ACC is now accepting abstract submissions across 60 topics, including the featured field of cardio-oncology, and complex clinical case submissions. Be part of the global stage where groundbreaking discoveries, real-world cases and innovative ideas converge. Submissions are due by Tuesday, Oct. 6 at 1 p.m. ET. Start your submission.
August 28, 2026
Join leading cardio-oncology experts online on Wednesday, Sept. 9 at noon ET for a discussion on the diagnosis, clinical presentation and management of immune checkpoint inhibitor (ICI)-related myocarditis, including patients with concurrent immune-related myopathy. Drawing on recent JACC: CardioOncology research, the discussion will explore cardiovascular outcomes, troponin interpretation and evolving treatment strategies to help clinicians navigate these complex cases. Reserve your spot today to earn 1 CME credit and gain practical insights from experts at the forefront of cardio-oncology care.
